KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 12 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,745 | 0.0% | 38,000 | 0.0% | 0.00% | – |
Q2 2023 | $25,745 | -11.2% | 38,000 | 0.0% | 0.00% | – |
Q1 2023 | $29,000 | -95.6% | 38,000 | -95.8% | 0.00% | – |
Q2 2022 | $655,000 | -77.5% | 900,000 | -74.6% | 0.00% | – |
Q1 2022 | $2,912,000 | -32.1% | 3,540,000 | -33.1% | 0.00% | – |
Q4 2021 | $4,289,000 | +73.8% | 5,290,000 | +60.8% | 0.00% | – |
Q3 2021 | $2,468,000 | -18.1% | 3,290,000 | +10.0% | 0.00% | – |
Q2 2021 | $3,012,000 | -9.0% | 2,990,000 | 0.0% | 0.00% | – |
Q1 2021 | $3,311,000 | -14.2% | 2,990,000 | +1.0% | 0.00% | -100.0% |
Q4 2020 | $3,860,000 | -44.2% | 2,960,000 | -45.8% | 0.00% | 0.0% |
Q3 2020 | $6,919,000 | +158.1% | 5,460,000 | +198.0% | 0.00% | – |
Q4 2019 | $2,681,000 | – | 1,832,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 9,000,000 | $6,561,000 | 2.60% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,050,000 | $22,600,000 | 0.52% |
Context Capital Management, LLC | 7,000 | $5,079,000 | 0.36% |
DeepCurrents Investment Group LLC | 11,890,000 | $8,569,000 | 0.34% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $18,139,000 | 0.31% |
CAPSTONE INVESTMENT ADVISORS, LLC | 5,500,000 | $4,046,000 | 0.02% |
LAZARD ASSET MANAGEMENT LLC | 17,500,000 | $12,872,000 | 0.02% |
BLB&B Advisors, LLC | 100,000 | $73,000 | 0.01% |
MACKAY SHIELDS LLC | 221,000 | $163,000 | 0.00% |
JPMORGAN CHASE & CO | 900,000 | $655,000 | 0.00% |